BLOOD RESEARCH Indexed in /covered by CAS, KoreaScience & DOI/Crossref:eISSN 2288-0011   pISSN 2287-979X

 

Cited by CrossRef (6)

  1. Rojin Park. Attempts to treat patients with hemophilia, the "royal disease". Blood Res 2013;48:235
    https://doi.org/10.5045/br.2013.48.4.235
  2. H. Takedani, J. Hirose, F. Minamoto, M. Kubota, J. Kinkawa, M. Noguchi. Major orthopaedic surgery for a haemophilia patient with inhibitors using a new bypassing agent. Haemophilia 2016;22:e459
    https://doi.org/10.1111/hae.13029
  3. Gerard Dolan, Jan Astermark, Cedric Hermans. Recombinant FVIIa in elective non‐orthopaedic surgery of adults with haemophilia and inhibitors: A systematic literature review. Haemophilia 2021;27
    https://doi.org/10.1111/hae.14291
  4. Hee Young Ju, Hye Lim Jang, Young Shil Park. The efficacy of bypassing agents in surgery of hemophilia patients with inhibitors. Blood Res 2015;50:173
    https://doi.org/10.5045/br.2015.50.3.173
  5. Matteo Rota, Paolo A. Cortesi, Roberto Crea, Alessandro Gringeri, Lorenzo G. Mantovani. Thromboembolic event rate in patients exposed to anti-inhibitor coagulant complex: a meta-analysis of 40-year published data. 2017;1:2637
    https://doi.org/10.1182/bloodadvances.2017011536
  6. Zühre Kaya, Özlem Orhan, Sacit Turanlı, İdil Yenicesu, Ülker Koçak, Türkiz Gürsel. Successful total hip replacement with sequential administration of bypassing agents in an adolescent boy with hemophilia A and high inhibitor titers. 2017;28:419
    https://doi.org/10.1097/MBC.0000000000000617